BiotechTube
Home/Prolifagen Therapeutics/Andreas Bader
AB

Andreas Bader

Consultant Chief Science Officer

Prolifagen Therapeutics

Therapeutic Areas

Cardiovascular DiseaseMyocardial Infarction

Prolifagen Therapeutics Pipeline

DrugIndicationPhase
PRO302Heart muscle regeneration post-myocardial infarctionPreclinical

Leadership Team at Prolifagen Therapeutics

MB
Mike Behr
Chief Executive Officer
KS
Kiernan Seth
Chief Development Officer
WH
Will Houston
Chief Financial Officer
CB
Claudine Bruck
Co-Founder & Board Chair
View full Prolifagen Therapeutics profile